Trial Profile
Effects of Dapagliflozin on Stabilizing Coronary Atherosclerotic Plaques: Using IB-IVUS Imaging Study
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 30 Dec 2020
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 23 Dec 2020 Status changed from not yet recruiting to discontinued.
- 05 Sep 2017 New trial record